Announcements Trials

Browse Landscape

Phase

Status

Terminated 4 Unknown 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 4 Sarcoma 2 Other hematologic neoplasm 2 Lymphoid 2 Thoracic 1 Gastrointestinal 1

Conditions

Interventions

Carboplatin 132 Cisplatin 129 Pemetrexed 114 Docetaxel 81 Drug Therapy 62 Gefitinib 57 anlotinib 55 Gemcitabine 55 Erlotinib Hydrochloride 55 Radiotherapy 48 Bevacizumab 48 pembrolizumab 47 Paclitaxel 47 Etoposide 44 apatinib 42 icotinib 41 camrelizumab 39 osimertinib 36 Nivolumab 33 Vinorelbine 31 Radiosurgery 30 sintilimab 29 durvalumab 25 aumolertinib 25 endostar protein 24 atezolizumab 22 Endostatins 22 toripalimab 19 Blood Specimen Collection 19 tislelizumab 18

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × selinexor × Thoracic × Clear all

NCT03466827 2018-03-15

TET-SEL

Rigshospitalet, Denmark

Phase 2 Unknown

Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡